The OrQA-UK (Organ Quality Assessment) trial: testing a new artificial intelligence tool to help increase the use of donated livers in the UK

OrQA-UK (Organ Quality Assessment): novel clinical trial of an AI enabled photograph assessment tool to improve organ utilisation in the United Kingdom

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN16126004

Enrollment

2040

Registered

2026-05-29

Start date

2026-08-01

Completion date

Unknown

Last updated

2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AI enabled photograph assessment tool to improve liver organ use in the United Kingdom Other

Interventions

Collection of follow up data from the NHSBT UK Transplant Registry, NHSBT statistician

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Donor family consent for research provided and no restrictions against commercial involvement, confirmed in TransplantPath 2. Donor liver with at least one back-bench image, confirmed in TransplantPath 3. Has assigned Donor ODT number, confirmed in TransplantPath 4. Donor type (DCD/DBD) provided, confirmed in TransplantPath 5. Liver image(s) passes OrQA image quality check, confirmed by the OrQA system 6. Liver image(s) passes OrQA liver/non-liver check, confirmed by the OrQA system 7. OrQA-L score completed by the OrQA system

Exclusion criteria

Exclusion criteria: 1. Living donor livers, confirmed in TransplantPath 2. Livers not offered through TransplantPath (e.g. Domino), confirmed in TransplantPath

Design outcomes

Secondary

Measure	Time frame
Measured using Data taken from the UK Transplant Registry at Between transplantation and 3 months post-transplant: 1. Proportion of recipients alive 2. Proportion of recipients with graft functioning at 3 months post-transplant 3. Proportion of recipients experiencing primary non-function 4. Proportion of recipients experiencing renal impairment 5. Proportion of recipients requiring reoperation due to haemorrhage 6. Proportion of recipients experiencing hepatic artery thrombosis 7. Proportion of recipients experiencing biliary tract leaks 8. Proportion of recipients experiencing biliary tract strictures requiring intervention 9. Proportion of recipients experiencing portal vein thrombosis 10. Proportion of recipients experiencing IVC/hepatic vein occlusion 11. Proportion of recipients experiencing post-operative wound sepsis 12. Proportion of recipients experiencing post-operative fungal infections 13. Mean number of treated rejection episodes since transplant	—

Measure

Time frame

Measured using Data taken from the UK Transplant Registry at Between transplantation and 3 months post-transplant: 1. Proportion of recipients alive 2. Proportion of recipients with graft functioning at 3 months post-transplant 3. Proportion of recipients experiencing primary non-function 4. Proportion of recipients experiencing renal impairment 5. Proportion of recipients requiring reoperation due to haemorrhage 6. Proportion of recipients experiencing hepatic artery thrombosis 7. Proportion of recipients experiencing biliary tract leaks 8. Proportion of recipients experiencing biliary tract strictures requiring intervention 9. Proportion of recipients experiencing portal vein thrombosis 10. Proportion of recipients experiencing IVC/hepatic vein occlusion 11. Proportion of recipients experiencing post-operative wound sepsis 12. Proportion of recipients experiencing post-operative fungal infections 13. Mean number of treated rejection episodes since transplant

—

Countries

United Kingdom

Contacts

Public ContactCharlotte Hickman

charlotte.hickman@nhsbt.nhs.uk+44 7553 525940

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jun 11, 2026